Q1 2022 Holdings
Filed 2022-05-12 | 139 holdings | $498.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $185.2M | 587,500 | 37.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $125.4M | 665,000 | 25.1% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $106.1M | 650,000 | 21.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $36.8M | 1,000,000 | 7.4% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $12.4M | 1,000,000 | 2.5% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $8.5M | 500,000 | 1.7% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $4.6M | 1,646,517 | 0.9% |
| Adagio Therapeutics Inc(IVVD) | COM | 00534A102 | $4.6M | 1,000,000 | 0.9% |
| Adagene Inc(ADAG) | ADS | 005329107 | $3.5M | 1,000,000 | 0.7% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $2.6M | 250,000 | 0.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $2.5M | 250,000 | 0.5% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $1.9M | 750,000 | 0.4% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $967.0K | 105,347 | 0.2% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $964.0K | 75,000 | 0.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $820.0K | 500,000 | 0.2% |
| WW Intl Inc(WW6) | COM | 98262P101 | $151.6K | 14,818,300 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $148.8K | 71,178,364 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $111.0K | 1,350,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $93.6K | 650,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $77.5K | 2,000,000 | 0.0% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $72.4K | 4,750,000 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $66.2K | 1,650,000 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $58.5K | 8,500,000 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $53.5K | 2,000,000 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $52.5K | 1,500,000 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $48.0K | 850,000 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $42.3K | 1,000,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $37.9K | 4,000,000 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $33.3K | 500,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $31.6K | 2,450,000 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $27.3K | 3,172,221 | 0.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $26.2K | 1,720,720 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $24.8K | 750,000 | 0.0% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $23.9K | 700,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $21.0K | 700,000 | 0.0% |
| Generation BIO Co(GBIOGBX) | COM | 37148K100 | $20.7K | 2,814,191 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $20.5K | 2,358,968 | 0.0% |
| Rubius Therapeutics Inc | COM | 78116T103 | $20.4K | 3,701,580 | 0.0% |
| Talaris Therapeutics Inc | COM | 87410C104 | $20.3K | 2,064,262 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $20.0K | 275,000 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $19.3K | 600,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $18.9K | 800,100 | 0.0% |
| Evotec AG(EVO) | SPONSORED ADS | 30050E105 | $17.4K | 1,149,425 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $16.9K | 1,050,000 | 0.0% |
| Eqrx Inc | COM | 26886C107 | $16.5K | 4,000,000 | 0.0% |
| Allovir Inc | COM | 019818103 | $15.7K | 2,323,371 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $15.3K | 900,000 | 0.0% |
| Intel Corp(INTC)Call | COM | 458140100 | $14.9K | 300,000 | 0.0% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $14.2K | 2,273,530 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $13.9K | 6,116,493 | 0.0% |